Catalyst Wire Dossier Catalyst Wire Dossier

LEO 124249 ointment 30 mg/g

LEO 124249 · LEO Pharma
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LEO 124249 ointment 30 mg/g, covering 2025-02-24 to 2025-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy of Twice Daily Application of LEO 124249 Ointment 30 mg/g for 12 Weeks on Eyebrow Alopecia Areata. [Phase 2]

See pricing